drugset / Trial / NCT00800618

A Study To Investigate How The Body Handles Multiple Doses Of PF-0243873 And To Investigate The Effect Of PF-02413873 On Sex Hormone Levels In Healthy Young Women

NCT00800618 ↗

Phase 1 Completed 42 enrolled Pfizer
RandomizedParallel-groupDouble-blindBasic science

Summary

The study will investigate how well multiple doses of PF-02413873 are tolerated by healthy young women, how the body handles multiple doses of PF-02413873 and which effect PF-02413873 has on sex hormones in healthy young women

Timeline

Start
2008-11
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-02413873 Unknown 20 mg Oral
Subject PF-02413873 Unknown 100 mg Oral
Subject PF-02413873 Unknown 500 mg Oral
Subject PF-02413873 Unknown 1500 mg Oral

Indications